BCI Minerals — Resilient iron ore price buoys Q220

BCI Minerals — Resilient iron ore price buoys Q220

In its December quarterly report, BCI Minerals confirmed that the strong performance exhibited by its Iron Valley royalty asset in Q120 continued into Q220. Iron Valley shipped 1.5Mt of iron ore in Q220 (cf 2.0Mt in Q120), comprising 60% fines (cf 65%), resulting in a quarterly EBITDA of A$3.2m, including a negative prior quarterly adjustment of A$1.6m (cf a near record quarterly EBITDA of A$7.7m in Q120). Notwithstanding the adjustment, BCI’s Q220 EBITDA of A$3.2m was nevertheless higher than any other quarter since Q317 except Q419 and Q120.

Lord Ashbourne

Written by

Lord Ashbourne

Director of Content, Mining

BCI Minerals

Resilient iron ore price buoys Q220

Quarterly update

Metals & mining

31 January 2020

Price

A$0.17

Market cap

A$68m

A$1.4805/US$

Net cash (A$m) at 31 December 2019

34.0

Shares in issue

397.6m

Free float

63%

Code

BCI

Primary exchange

ASX

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(2.9)

(5.7)

22.2

Rel (local)

(5.5)

(9.9)

2.3

52-week high/low

A$0.22

A$0.14

Business description

BCI Minerals has two major assets in Western Australia, including a 100% interest in the Mardie salt and potash project and a royalty-type interest in the Iron Valley iron ore mine operated by Mineral Resources.

Next events

Mardie DFS

Q2 CY20

Large-scale trial pond construction

Q2 CY20

Mardie investment decision

Q3 CY20

Mardie project construction

Early 2021

Analyst

Charles Gibson

+44 (0)20 3077 5724

BCI Minerals is a research client of Edison Investment Research Limited

In its December quarterly report, BCI Minerals confirmed that the strong performance exhibited by its Iron Valley royalty asset in Q120 continued into Q220. Iron Valley shipped 1.5Mt of iron ore in Q220 (cf 2.0Mt in Q120), comprising 60% fines (cf 65%), resulting in a quarterly EBITDA of A$3.2m, including a negative prior quarterly adjustment of A$1.6m (cf a near record quarterly EBITDA of A$7.7m in Q120). Notwithstanding the adjustment, BCI’s Q220 EBITDA of A$3.2m was nevertheless higher than any other quarter since Q317 except Q419 and Q120.

Year end

Revenue (A$m)

PBT*
(A$m)

EPS*
(c)

DPS
(c)

P/E
(x)

Yield
(%)

06/18

33.0

(16.9)

(4.3)

0.0

N/A

N/A

06/19

54.2

(4.6)

(0.8)

0.0

N/A

N/A

06/20e

87.1

(12.5)

(3.1)

0.0

N/A

N/A

06/21e

56.1

3.0

0.3

0.0

54.4

N/A

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles and exceptional items.

Major share price catalyst in the form of Mardie DFS

The timetable surrounding Mardie has slipped by an immaterial one quarter, with the DFS now expected in Q2 CY20 (from Q1 CY20 previously) and a final investment decision in Q3 CY20. More significantly, in our report Gold stars and Black holes: Analysing the discount: From resource to sanction, published in January 2019, we observed that, excluding outliers, the average valuation of companies with projects at PFS stage is 9.9% of attributable NPV. On this basis (and assuming a post-tax NPV of 70% of pre-tax NPV of A$560m), an average valuation for Mardie currently would be A$38.8m, or 9.76 Australian cents per share (ie 29% of our current BCI valuation – see below). However, if the DFS on Mardie, which is underway, is completed on approximately the same terms as the optimised PFS, we would expect this valuation to increase approximately threefold, to c 30.9% of NPV, or 28.34c per BCI share (ie 1.7x BCI’s current share price) for Mardie alone, excluding BCI’s other assets such as Iron Valley, Buckland.

Salt price simultaneously on the rise

As BCI is progressing its DFS, it also reports that for the 10 months to October 2019, international trade data confirms that the average value of Australian salt exported to Asia has risen by 20% compared to the 2018 average price.

Valuation: 2x share price, potentially 2.8x

Since our last note, we have adjusted our valuation solely for changes in the share price (which affects future assumed dilution) and the US$/A$ forex rate, with the result that our updated valuation per BCI share remains largely unchanged at 33.75c (cf 34.13 previously). However, this valuation increases to as much as 45.82c (44.38c previously) if the iron ore price remains at current levels. Note that a further 2.43c should be added to all of these valuations to account for the value of BCI’s Buckland iron ore assets.

Iron Valley quarterly update

In its December quarterly report (released on 24 January), BCI confirmed that the strong performance exhibited by its Iron Valley royalty asset in Q120 continued into Q220. Iron Valley shipped 1.5Mt of iron ore in Q220 (cf 2.0Mt in Q120), comprising 60% fines (cf 65% in Q120), resulting in quarterly EBITDA of A$3.2m, including a negative prior quarterly adjustment of A$1.6m. This compared with a record quarterly cash flow of A$10.7m in Q120, albeit with the expectation of a negative price finalisation adjustment of approximately A$3.0m to be realised in Q220 (for EBITDA of A$7.7m). Notwithstanding the prior quarterly adjustment, BCI’s December’s quarter EBITDA of A$3.2m was nevertheless higher than at any other time since Q317, with the sole exceptions of Q419 and Q120.

Exhibit 1: Iron Valley quarterly EBITDA attributable to BCI (A$m)

Source: BCI Minerals.

Although the price of 58% CFR iron ore (a close proxy to the price received by Iron Valley for its product) has declined by c 27% since its peak of US$106.5/t in mid-July 2019, it has since stabilised and traded generally within the range US$74/t ±US$4/t, with the result that (on average) it is tracking relatively close to Edison’s original expectation for FY20 (see our note, BCI Minerals: Iron ore price continues to power ahead, published on 5 July 2019). On current trends therefore (the grey line in Exhibit 2 below) the average price of 58% CFR iron ore for BCI’s FY20 will be US$71.02/t, compared with an original expectation (the green line) of an average price of US$71.53/t:

Exhibit 2: Price of standard grade 58% CFR iron ore, July 2014 to July 2020e

Source: Refinitiv, Edison Investment Research

Moreover, despite the well-documented price falls of both 58% and 62% iron ore, the price of the former has apparently stabilised at a historically modest discount relative to the latter – more akin to market conditions before November 2016 than those experienced during the period between November 2016 and January 2019, prior to Vale’s Brumadinho tailings dam disaster:

Exhibit 3: 62% iron ore price (US$/t) and 58% iron ore price, July 2014 to present

Exhibit 4: Discount of 58% iron ore price to 62% iron ore price, July 2014 to present (%)

Source: Refinitiv

Source: Edison Investment Research (underlying data: Refinitiv)

Exhibit 3: 62% iron ore price (US$/t) and 58% iron ore price, July 2014 to present

Source: Refinitiv

Exhibit 4: Discount of 58% iron ore price to 62% iron ore price, July 2014 to present (%)

Source: Edison Investment Research (underlying data: Refinitiv)

As a result, we are leaving our earnings forecasts for FY20 and subsequent years substantially unchanged (with the exception of adjusting for forex and the share price, which affects future assumed equity dilution for the development of Mardie).

Mardie update

A definitive feasibility study (DFS) on the Mardie salt and potash project is underway and is expected to be completed in Q2 CY20. Salient features of progress made during the December quarter are summarised below:

Design and engineering of all key salt and sulphate of potash (SOP) production, port and support infrastructure has been completed as well as production ramp-up schedules. As a result, preliminary capital and operating cost estimates are being compiled and validated at the same time as a value engineering process is underway to optimise designs and reduce capex and opex, which is expected to be completed by end-Q1 CY20.

BCI is conducting evaporation trials at the Mardie site, comprising 21 pan evaporators plus a 1:40,000 scale version of the entire future pond and crystalliser configuration. The 1:40,000 small-scale trial ponds have been fully constructed and are now operating at steady-state, providing samples for test work and marketing.

In addition to its small-scale evaporation trials, BCI is planning to undertake (and has received environmental approval for) a large-scale trial pond programme that will include construction of a c A$12m (A$15m including camp that has already been built), 32ha trial pond (including 2.3km of pond walls, some of which are final seawalls for the project’s Pond 1) and a seawater intake facility incorporating one of the proposed six operating pumps. The principal rationale of the large-scale pond trial is to test the envisaged method of constructing the evaporation pond walls and the materials involved (especially the construction time available per day in the inter-tidal area), thereby substantially mitigating future construction risk. In addition, it will validate the permeability of the underlying clay soils over a large area, validate evaporation assumptions over a large area and validate pump rates and capabilities. Design work for the large-scale ponds and construction of a 36-bed accommodation village has been completed and construction of the trial pond itself is due to commence in Q2 CY20 after the end of the wet season.

BCI submitted a draft environmental review document (ERD) for the Mardie project to the Western Australian Environmental Protection Authority (EPA) in April 2019. Since then, it has revised the draft to incorporate improvements to the project layout and feedback from the EPA and other government departments and agencies. The final ERD is expected to be submitted in the current quarter (Q1 CY20) and released for public comment in Q2 CY20 (cf Q4 CY19 previously) with EPA endorsement targeted for H2 CY20 (cf Q2 CY20 previously).

Mining Lease applications (together with their supporting Mining Proposal and Mine Closure Plan documents) were submitted to the regulator during the quarter under review and are expected to be granted by Q3 CY20.

The port land and marine areas required for the project were identified with the Pilbara Ports Authority (PPA) during 2019 and the Department of Planning, Lands & Heritage is expected to formally secure tenure during 2020. At the same time, a non-binding term sheet has been executed with the PPA, setting out the key principles, process and timeline for the finalisation of the Mardie Port lease documentation, which is currently being drafted and reviewed.

Additional memoranda of understanding (MoUs) were agreed with Asian chemical companies and traders during the quarter. As a result, BCI now has 10 MoUs (vs six previously) that cover 2.8Mtpa, or 70% (cf 2.4Mtpa and 60%) of Mardie’s planned steady-state salt output and two MoUs (vs one previously) that cover 80ktpa, or 80% (cf 10ktpa and 10%), of its planned steady-state SOP output over a period of three years. Note that BCI reports that positive discussions are ongoing with a number of other salt and SOP end-users and traders and that BCI is aiming to secure additional salt MoUs in the coming months.

Finally, in respect of funding, securing long tenor debt is an important part of Mardie’s strategy, to which end it is progressing through the Due Diligence Stage (the third of four stages) of the Federal Government’s Northern Australia Infrastructure Facility (NAIF) assessment process. It is also advancing discussions and indicative term sheets with Australian and international commercial banks for the provision of project finance debt to complement any NAIF debt facilities.

Valuation

As stated previously, the only assumptions to change in our valuation are BCI’s share price (which has fallen fractionally from 18c at the time of our last note to 17c currently) and the A$/US$ rate (which has weakened from A$1.4582/US$ to A$1.4805/US$). The remainder of our assumptions remain unchanged with the result that our long-term estimates of BCI’s earnings, (maximum potential) dividends per share and valuation trajectory are also substantially unchanged as follows:

Exhibit 5: BCI EPS and (maximum potential) DPS forecasts, FY18–84e (cents)

Source: Edison Investment Research. Note: Income derived from Iron Valley and Mardie, combined; no contribution assumed from Buckland or any other assets.

Discounting at our customary discount rate of 10% per year, the (fully diluted) value of these cash flows to shareholders is 33.75 Australian cents (cf 34.13c previously). To this should then be added a further 2.43c for BCI’s Buckland iron ore assets to take the total to 36.18c.

Sensitivities

All other things being equal, our near-term earnings forecasts in particular will be affected by the extent to which iron ore prices either remain at current levels or decline as shown in Exhibit 2. As can be seen in Exhibit 6, we calculate that, if iron ore prices remain at current levels (58% CFR at US$78/t) and all other things remain equal, BCI’s valuation will rise by 15.5%, from 33.75c/share to 38.98c/share. In addition, if the company takes the opportunity to reduce future equity funding as a result of a higher iron ore price, the valuation instead increases by 35.8% to 45.82c/share:

Exhibit 6: BCI Minerals valuation sensitivity to future Iron Valley iron ore pricing scenarios

Scenario

Valuation (Australian cents per share)

Incremental change (c/share)

Incremental change (%)

Maximum net debt funding requirement (A$m)

Maximum leverage* (%)

Base case

33.75

271.4

49.9

Iron ore price remains at current level until end of life of mine

38.98

+5.23

+15.5

209.8

38.3

Ditto with reduced future equity funding requirement

45.82

+12.07

+35.8

273.9

50.0

Source: Edison Investment Research. Note: *Defined as (net debt)/(net debt+equity).

Financials

BCI’s cash flow is necessarily somewhat lumpy. Its September 2019 quarter net receipts of A$10.7m, for example, were received in October 2019 and its December quarter net receipts of A$1.5m will be received by the end of January 2020, reflecting provisional December quarter net receipts less total finalisation adjustments relating to the September quarter. Nevertheless, the robust performance exhibited by Iron Valley so far is FY20 is acting to substantially defray the ongoing costs of Mardie DFS and early development costs, as demonstrated by the cash balances declared by the company in recent months (below):

Exhibit 7: BCI recently reported net cash, December 2018 to December 2019

Date

End-Dec 2018

End-Mar 2019

End-May 2019

End-Jun 2019

End-Sept 2019

End-Nov 2019

End-Dec 2019

BCI net cash (A$m)

36.6

35.4

34.8

33.7

32.3

37.3

34.0

Net cash per BCI share (cents)

9.3

8.9

8.8

8.5

8.1

9.4

8.6

Source: BCI Minerals.

We expect BCI’s net cash position to reduce quite materially in H2FY20, in particular under the capex influence of the construction of the large-scale trial pond. Nevertheless, at this time, we forecast it to remain at a healthy A$20.1m as at end-June 2020, prior to BCI making a final investment decision on the Mardie project in Q3 CY20 (see Exhibit 8, below).

Exhibit 8: Financial summary

A$'000s

2015

2016

2017

2018

2019

2020e

2021e

June

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

PROFIT & LOSS

Revenue

 

 

281,211

151,279

64,324

33,029

54,170

87,086

56,069

Cost of Sales

(278,465)

(158,210)

(55,190)

(47,442)

(56,781)

(97,481)

(50,713)

Gross Profit

2,746

(6,931)

9,134

(14,413)

(2,611)

(10,395)

5,356

EBITDA

 

 

2,746

(6,931)

9,134

(14,413)

(2,611)

(10,395)

5,356

Operating Profit (before amort. and except.)

(26,090)

(12,622)

5,665

(17,330)

(5,234)

(13,018)

2,733

Intangible Amortisation

0

0

0

0

0

0

0

Exceptionals

(170,881)

(40,108)

(302)

0

15,991

0

0

Other

(2,935)

812

(5)

0

0

0

0

Operating Profit

(199,906)

(51,918)

5,358

(17,330)

10,757

(13,018)

2,733

Net Interest

(3,505)

(951)

311

420

630

506

302

Profit Before Tax (norm)

 

 

(29,595)

(13,573)

5,976

(16,910)

(4,604)

(12,513)

3,035

Profit Before Tax (FRS 3)

 

 

(203,411)

(52,869)

5,669

(16,910)

11,387

(12,513)

3,035

Tax

44,912

(27,086)

0

0

1,510

0

0

Profit After Tax (norm)

12,382

(39,847)

5,971

(16,910)

(3,094)

(12,513)

3,035

Profit After Tax (FRS 3)

(158,499)

(79,955)

5,669

(16,910)

12,897

(12,513)

3,035

Average Number of Shares Outstanding (m)

174.8

196.2

316.7

394.6

397.2

397.6

956.8

EPS - normalised (c)

 

 

7.1

(20.3)

1.9

(4.3)

(0.8)

(3.1)

0.3

EPS - normalised and fully diluted (c)

 

7.1

(19.5)

1.9

(4.3)

(0.8)

(3.1)

0.3

EPS - (IFRS) (c)

 

 

(90.7)

(40.8)

1.8

(4.3)

3.2

(3.1)

0.3

Dividend per share (p)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Gross Margin (%)

1.0

-4.6

14.2

-43.6

-4.8

-11.9

9.6

EBITDA Margin (%)

1.0

-4.6

14.2

-43.6

-4.8

-11.9

9.6

Operating Margin (before GW and except.) (%)

-9.3

-8.3

8.8

-52.5

-9.7

-14.9

4.9

BALANCE SHEET

Fixed Assets

 

 

154,904

86,546

78,059

85,768

74,075

78,452

184,389

Intangible Assets

60,237

33,618

33,063

43,615

34,392

41,392

37,392

Tangible Assets

94,667

52,928

44,996

42,153

39,683

37,060

146,997

Investments

0

0

0

0

0

0

0

Current Assets

 

 

102,374

23,204

46,429

20,270

56,293

38,937

110,354

Stocks

9,886

61

0

0

0

119

77

Debtors

24,427

13,694

10,053

7,213

22,251

18,344

13,825

Cash

67,671

9,449

36,376

13,057

33,702

20,133

96,112

Other

390

0

0

0

340

340

340

Current Liabilities

 

 

(77,222)

(21,769)

(12,107)

(9,373)

(18,092)

(17,625)

(11,322)

Creditors

(70,947)

(19,749)

(12,107)

(9,373)

(18,092)

(17,625)

(11,322)

Short term borrowings

(6,275)

(2,020)

0

0

0

0

0

Long Term Liabilities

 

 

(20,773)

(11,307)

(5,225)

(6,054)

(8,664)

(8,664)

(8,664)

Long term borrowings

0

0

0

0

0

0

0

Other long term liabilities

(20,773)

(11,307)

(5,225)

(6,054)

(8,664)

(8,664)

(8,664)

Net Assets

 

 

159,283

76,674

107,156

90,611

103,612

91,099

274,758

CASH FLOW

Operating Cash Flow

 

 

(77,686)

(19,721)

11,860

(11,957)

(7,663)

(7,074)

3,614

Net Interest

(1,120)

0

0

0

0

506

302

Tax

44,912

(27,086)

0

0

1,510

0

0

Capex

(10,987)

(8,075)

(2,220)

(10,074)

(496)

(7,000)

(112,560)

Acquisitions/disposals

24,338

0

(5,151)

(1,288)

27,294

0

4,000

Financing

6,118

1,510

24,403

0

0

0

180,623

Dividends

(18,652)

0

0

0

0

0

0

Net Cash Flow

(33,077)

(53,372)

28,892

(23,319)

20,645

(13,569)

75,979

Opening net debt/(cash)

 

 

(94,473)

(61,396)

(7,429)

(36,376)

(13,057)

(33,702)

(20,133)

HP finance leases initiated

0

0

0

0

0

0

0

Other

0

(595)

55

0

0

0

0

Closing net debt/(cash)

 

 

(61,396)

(7,429)

(36,376)

(13,057)

(33,702)

(20,133)

(96,112)

Source: Company sources, Edison Investment Research


General disclaimer and copyright

This report has been commissioned by BCI Minerals and prepared and issued by Edison, in consideration of a fee payable by BCI Minerals. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2020. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by BCI Minerals and prepared and issued by Edison, in consideration of a fee payable by BCI Minerals. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2020. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Hutchison China MediTech — 2020 insights into a breakout year

2019 has been a landmark year and we expect momentum to accelerate as Hutchison China MediTech (HCM) continues on its path to become a global biotech with a marketed portfolio of innovation-led oncology drugs. Achievements in 2019 include the addition of Elunate on China’s exclusive NRDL list and surufatinib’s China NDA submission following impressive data in NET. 2020–21 are pivotal years. Surufatinib should become the second asset to launch in China, partner AZN could launch savolitinib in China for NSCLC (MET Exon 14) in 2021 and, importantly, this drug could be the first of HCM’s innovation assets to launch globally in 2022 (for c-Met positive NSCLC in combination with Tagrisso, a blockbuster opportunity). We think recent underperformance is unjustified given the emerging strength of its broad, late-stage innovation pipeline and the opportunity for long-term growth and enhanced economic returns.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free